SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.350-7.1%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (615)11/25/1998 2:58:00 PM
From: Anthony Wong  Read Replies (2) of 2539
 
Monsanto stock rises by 5.8 pct.
[St. Louis is Monsanto's home town]

Wednesday, November 25, 1998

By [Robert Steyer
Of The Post-Dispatch
Monsanto Co.'s stock rose 5.8 percent Tuesday, one day after the company
received a favorable bond rating and revealed some details of its financial
independence plan
. The shares were up $2.38 to $43.38.

On Monday, Standard & Poor's Corp. reaffirmed its investment grade ratings on
Monsanto's long-term debt and commercial paper. The ratings are important to
Monsanto's money-raising efforts
after last month's collapse of merger talks with
American Home Products Corp.

Last week, two other firms slightly downgraded Monsanto's debt, but the ratings
remain investment grade
. The ratings will determine Monsanto's cost of issuing
$2.5 billion in long-term, unsecured debt - perhaps as early as next week.

The debt is part of a financial package, announced two weeks ago, as Monsanto
tries to show Wall Street it can survive as an independent company that will cut
its debt and also maintain adequate support for research and marketing. The
package includes raising at least $1 billion by selling some assets.

In the transactions announced Monday:

* Monsanto will sell $900 million in stock - 22.5 million shares at $40 a share.

* Underwriters can offer 2.46 million more shares if the stock offering attracts a
stampede of investors,

* Monsanto will offer $700 million worth of a hybrid product called an
adjustable conversion-rate equity security.

The company, which predicts it will clear $1.55 billion after transaction
costs, expects these securities to be sold by Nov. 30. The money will help
Monsanto complete a pair of big seed company acquisitions.

Copyright (c) 1998, St. Louis Post-Dispatch

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext